BMC Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Oct. 31, 2024
Transmembrane
9
superfamily
member
1
(TM9SF1)
is
involved
in
inflammation.
Since
both
inflammatory
and
autoimmune
diseases
are
linked
to
immune
cells
regulation,
this
study
investigated
the
association
between
TM9SF1
expression
disease
activity.
As
B
cell
differentiation
autoantibody
production
exacerbate
disease,
signaling
pathways
these
processes
were
explored.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Aug. 24, 2023
The
proper
transfer
of
genetic
information
from
DNA
to
RNA
protein
is
essential
for
cell-fate
control,
development,
and
health.
Methylation
DNA,
RNAs,
histones,
non-histone
proteins
a
reversible
post-synthesis
modification
that
finetunes
gene
expression
function
in
diverse
physiological
processes.
Aberrant
methylation
caused
by
mutations
or
environmental
stimuli
promotes
various
diseases
accelerates
aging,
necessitating
the
development
therapies
correct
disease-driver
imbalance.
In
this
Review,
we
summarize
operating
system
across
central
dogma,
which
includes
writers,
erasers,
readers,
reader-independent
outputs.
We
then
discuss
how
dysregulation
contributes
neurological
disorders,
cancer,
aging.
Current
small-molecule
compounds
target
modifiers
show
modest
success
certain
cancers.
methylome-wide
action
lack
specificity
lead
undesirable
biological
effects
cytotoxicity,
limiting
their
therapeutic
application,
especially
with
monogenic
cause
different
directions
changes.
Emerging
tools
capable
site-specific
manipulation
hold
great
promise
solve
dilemma.
With
refinement
delivery
vehicles,
these
new
are
well
positioned
advance
basic
research
clinical
translation
field.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Nov. 26, 2024
Epigenetics
governs
a
chromatin
state
regulatory
system
through
five
key
mechanisms:
DNA
modification,
histone
RNA
remodeling,
and
non-coding
regulation.
These
mechanisms
their
associated
enzymes
convey
genetic
information
independently
of
base
sequences,
playing
essential
roles
in
organismal
development
homeostasis.
Conversely,
disruptions
epigenetic
landscapes
critically
influence
the
pathogenesis
various
human
diseases.
This
understanding
has
laid
robust
theoretical
groundwork
for
developing
drugs
that
target
epigenetics-modifying
pathological
conditions.
Over
past
two
decades,
growing
array
small
molecule
targeting
such
as
methyltransferase,
deacetylase,
isocitrate
dehydrogenase,
enhancer
zeste
homolog
2,
have
been
thoroughly
investigated
implemented
therapeutic
options,
particularly
oncology.
Additionally,
numerous
epigenetics-targeted
are
undergoing
clinical
trials,
offering
promising
prospects
benefits.
review
delineates
epigenetics
physiological
contexts
underscores
pioneering
studies
on
discovery
implementation
drugs.
include
inhibitors,
agonists,
degraders,
multitarget
agents,
aiming
to
identify
practical
challenges
avenues
future
research.
Ultimately,
this
aims
deepen
epigenetics-oriented
strategies
further
application
settings.
Cell Death Discovery,
Journal Year:
2023,
Volume and Issue:
9(1)
Published: June 23, 2023
Abstract
Pathogens
or
danger
signals
trigger
the
immune
response.
Moderate
response
activation
removes
pathogens
and
avoids
excessive
inflammation
tissue
damage.
Histone
demethylases
(KDMs)
regulate
gene
expression
play
essential
roles
in
numerous
physiological
processes
by
removing
methyl
groups
from
lysine
residues
on
target
proteins.
Abnormal
of
KDMs
is
closely
associated
with
pathogenesis
various
inflammatory
diseases
such
as
liver
fibrosis,
lung
injury,
autoimmune
diseases.
Despite
becoming
exciting
targets
for
diagnosing
treating
these
diseases,
role
enzymes
regulation
still
unclear.
Here,
we
review
underlying
mechanisms
through
which
immune-related
pathways
responses.
In
addition,
also
discuss
future
applications
inhibitors
Circulation Research,
Journal Year:
2025,
Volume and Issue:
136(2), P. 232 - 254
Published: Jan. 16, 2025
Access
to
excess
dietary
sodium
has
heightened
the
risk
of
cardiovascular
diseases,
particularly
affecting
individuals
with
salt
sensitivity
blood
pressure.
Our
research
indicates
that
innate
antigen-presenting
immune
cells
contribute
rapid
pressure
increases
in
response
intake.
Emerging
evidence
suggests
epigenetic
reprogramming,
subsequent
transcriptional
and
metabolic
changes,
allows
these
have
a
sustained
repetitive
stimuli.
Epigenetic
mechanisms
also
steer
T-cell
differentiation
signaling.
Immune
respond
environmental
nutritional
cues,
such
as
salt,
promoting
regulation
changes.
This
article
aims
identify
discuss
role
system
contributing
salt-sensitive
hypertension.
Clinical and Translational Medicine,
Journal Year:
2024,
Volume and Issue:
14(3)
Published: March 1, 2024
The
interplay
between
the
immune
system
and
metabolic
state
of
a
cell
is
intricate.
In
all
phases
an
response,
corresponding
changes
shall
occur
to
support
its
modulation,
in
addition
signalling
through
cytokine
environment
receptor
stimulation.
While
autoimmune
disorders
may
develop
because
imbalance
that
modulates
switching
T-cell
phenotypes,
effects
interaction
T
B
cells
have
on
one
another's
cellular
metabolism
are
yet
be
understood
disease
context.
Here,
we
propose
perspective
which
highlights
potential
targeting
modulate
T-
B-cell
subtypes
populations
as
well
T-B
B-T
interactions
successfully
treat
disorders.
Specifically,
envision
how
can
tip
balance
interactions,
definite
mechanisms
both
health
disease,
explain
phenotype
switches
cells.
Within
this
scenario,
highlight
link
inflammation,
immunometabolism,
epigenetics
ageing,
critical
understand
inflammatory
combination
treatments
cause
(T/B)
imbalances,
pathways
involved,
increase
effectiveness
treatment
disorders,
and/or
ameliorate
their
symptoms
improve
patients'
quality
life.
Rheumatology Science and Practice,
Journal Year:
2023,
Volume and Issue:
61(4), P. 397 - 420
Published: Aug. 31, 2023
Two
fundamental
pathologic
processes
are
central
to
the
spectrum
of
chronic
inflammation
mechanisms:
autoimmunity
and
autoinflammation.
Autoimmunity
autoinflammation
mutually
potent
processes;
their
development
is
considered
within
framework
“immunoinflammatory”
continuum,
reflecting
close
relationship
between
innate
acquired
types
immune
response.
leading
mechanism
pathogenesis
a
large
group
inflammatory
human
diseases,
defined
as
autoimmune
frequency
which
in
population
exceeds
10%.
Advances
molecular
biology,
pharmacogenetics
bioinformatics
have
created
prerequisites
for
individualization
therapy
rheumatic
diseases
concept
personalized
medicine.
The
study
immunopathogenesis
mechanisms,
improvement
diagnostics,
deciphering
nature
taxonomy,
approaches
prevention
among
priority
directions
medicine
21st
century.
Immunity Inflammation and Disease,
Journal Year:
2023,
Volume and Issue:
11(12)
Published: Dec. 1, 2023
Abstract
Background
Autoimmune
diseases
(AD)
are
severe
pathophysiological
ailments
that
stimulated
by
an
exaggerated
immunogenic
response
towards
self‐antigens,
which
can
cause
systemic
or
site‐specific
organ
damage.
An
array
of
complex
genetic
and
epigenetic
facets
majorly
contributes
to
the
progression
AD,
thus
providing
significant
insight
into
regulatory
mechanism
microRNA
(miRNA).
miRNAs
short,
non‐coding
RNAs
have
been
identified
as
essential
contributors
post‐transcriptional
regulation
host
genome
expression
crucial
regulators
a
myriad
biological
processes
such
immune
homeostasis,
T
helper
cell
differentiation,
central
peripheral
tolerance,
development.
Aims
This
article
tends
deliberate
conceptualize
brief
pathogenesis
pertinent
well
miRNA
networks
affecting
five
different
ADs
namely
rheumatoid
arthritis
(RA),
type
1
diabetes,
multiple
sclerosis
(MS),
lupus
erythematosus
(SLE)
inflammatory
bowel
disorder
(IBD)
thereby
novel
miRNA‐based
theranostic
interventions.
Results
&
Discussion
Pertaining
differential
attributed
in
target
tissues
cellular
bodies
innate
adaptive
immunity,
paradigm
scientific
expeditions
suggests
optimistic
correlation
between
dysfunction
alterations.
Conclusion
Therefore,
it
is
not
astonishing
dysregulations
patterns
now
recognized
wide
spectrum
disorders,
establishing
themselves
potential
biomarkers
therapeutic
targets.
Owing
its
potencies,
targets
widely
utilized
development
biosensors
other
molecules
originating
from
same.
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: April 9, 2024
Multiple
myeloma
(MM)
is
an
incurable
hematological
disease
characterized
by
the
uncontrolled
growth
of
plasma
cells
primarily
in
bone
marrow.
Although
its
treatment
consists
administration
combined
therapy
regimens
mainly
based
on
immunomodulators
and
proteosome
inhibitors,
MM
remains
incurable,
most
patients
suffer
from
relapsed/refractory
with
poor
prognosis
survival.
The
robust
results
achieved
immunotherapy
targeting
MM-associated
antigens
CD38
CD319
(also
known
as
SLAMF7)
have
drawn
attention
to
development
new
immune-based
strategies
different
innovative
compounds
MM,
including
monoclonal
antibodies,
antibody-drug
conjugates,
recombinant
proteins,
synthetic
peptides,
adaptive
cellular
therapies.
In
this
context,
Syndecan1
(CD138
or
SDC1),
a
transmembrane
heparan
sulfate
proteoglycan
that
upregulated
malignant
cells,
has
gained
increasing
panorama
target
antigens,
since
key
role
tumorigenesis,
progression
aggressiveness
been
largely
reported.
Here,
our
aim
provide
overview
important
aspects
investigate
molecular
functions
CD138
physiologic
cell
states.
addition,
we
will
shed
light
CD138-based
therapeutic
approaches
currently
being
tested
preclinical
and/or
clinical
phases
discuss
their
properties,
mechanisms
action
applications.